CD40 and myeloid sarcoma: Given the close relationship between aberrant CD40 and autoimmunity (76–78), downregulating the B cell NF-κB pathway, which is a major signaling cascade, by CD40 stimulation may reverse the hyperresponsiveness of B cells induced by CD40 in MS patients.